RFA can activate the immune response and promote the infiltration of various relevant cells, including antigen‐presenting cells (APCs) such as dendritic cells (DCs), and tumor‐killing cells such as CD8+ T and natural killer (NK) cells, to exert antitumor efficacy. This evidence concerns the gene CD8A and neoplasm.